Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Avigad

Standardisation and Consensus Guidelines for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) by Real-Time Quantitative Reverse Transcriptase PCR of E1a2 BCR-ABL1

Leukemia

English

Related publications

Quantification of Minimal Residual Disease in Patients With E1a2 BCR-ABL-positive Acute Lymphoblastic Leukemia Using a Real-Time RT-PCR Assay

English

A Certified Plasmid Reference Material for the Standardisation of BCR–ABL1 mRNA Quantification by Real-Time Quantitative PCR

English

Monitoring of Minimal Residual Disease (MRD) by Real-Time Quantitative Reverse Transcription PCR (RQ-RT-PCR) in Childhood Acute Myeloid Leukemia With AML1/ETO Rearrangement

English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy

Oncology

Pharmacology

2018

English

Immunoglobulin Kappa Deleting Element Rearrangements in Precursor-B Acute Lymphoblastic Leukemia Are Stable Targets for Detection of Minimal Residual Disease by Real-Time Quantitative PCR

English

Improved Assessment of Minimal Residual Disease in B Cell Malignancies Using Fluorogenic Consensus Probes for Real-Time Quantitative PCR

English

A Patient With Philadelphia-Negative Acute Lymphoblastic Leukemia With a FISH-Negative Cryptic BCR-ABL1 Rearrangement Detected by PCR and Sequencing Analysis

Hematology & Transfusion International Journal

2015

English

CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients

Clinical Cancer Research

Cancer Research

Oncology

2011

English

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Avigad

Standardisation and Consensus Guidelines for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) by Real-Time Quantitative Reverse Transcriptase PCR of E1a2 BCR-ABL1

Related publications

Quantification of Minimal Residual Disease in Patients With E1a2 BCR-ABL-positive Acute Lymphoblastic Leukemia Using a Real-Time RT-PCR Assay

A Certified Plasmid Reference Material for the Standardisation of BCR–ABL1 mRNA Quantification by Real-Time Quantitative PCR

Monitoring of Minimal Residual Disease (MRD) by Real-Time Quantitative Reverse Transcription PCR (RQ-RT-PCR) in Childhood Acute Myeloid Leukemia With AML1/ETO Rearrangement

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

Immunoglobulin Kappa Deleting Element Rearrangements in Precursor-B Acute Lymphoblastic Leukemia Are Stable Targets for Detection of Minimal Residual Disease by Real-Time Quantitative PCR

Improved Assessment of Minimal Residual Disease in B Cell Malignancies Using Fluorogenic Consensus Probes for Real-Time Quantitative PCR

A Patient With Philadelphia-Negative Acute Lymphoblastic Leukemia With a FISH-Negative Cryptic BCR-ABL1 Rearrangement Detected by PCR and Sequencing Analysis

CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay